Right, before you go anywhere near a website or a form, sit down for two minutes and read this bit. Enclomiphene is a genuine bit of kit with a proper track record in the trials, and it also comes with an awkward paperwork problem, and both of those things matter a lot more than whether some provider’s homepage looks flash. It’s a selective estrogen receptor modulator, which is a mouthful for “it nudges your own body into making more testosterone” rather than handing you someone else’s. In the studies it did that job while leaving sperm production alone, which is exactly why blokes reach for it instead of the standard testosterone shot. Here’s the catch: there’s no FDA-approved finished product on the shelf. The branded version never got signed off, so every proper prescription today is compounded, written by a clinician and made up by a licensed compounding pharmacy. Every clinical claim below links straight to the source. Go and check it if you like.
Last updated June 2026. This is a prescription medicine, not a supplement, and definitely not something you source from a research-chemical seller because it’s cheaper. Don’t decide anything off this page alone. Get a clinician who’s actually looked at your bloodwork first.
The job you’re actually hiring this drug to do
If your testosterone’s come in low and you’re the type who’s younger, or wants kids, or just doesn’t fancy being on injections for the rest of your life, standard testosterone replacement has a real downside: it can shut your own sperm production down. Enclomiphene is built for a different job. It works on the signal from the brain rather than dumping testosterone in from outside, and in the trials it raised testosterone while leaving sperm counts where they were. That’s the whole pitch. It’s not for everyone with low T, it’s for a specific man with a specific problem.
Most of what turns up when you search for this drug is a race to the bottom on two numbers: how cheap and how fast. That’s the wrong way to shop for a hormone-axis medicine. This isn’t a multivitamin. It reaches into the signalling between your brain and your testicles and changes how the whole system runs. A low price on the capsule tells you nothing about whether anyone is watching what that change is doing to your estrogen, your mood, or your bloodwork three months down the line.
So here’s how I’ve graded the providers, on the things that actually decide whether this is done right, not on who’s cheapest or quickest.
What you’re actually buying (know your material before you buy it)
Enclomiphene is one half of clomiphene citrate, the old fertility drug. Clomiphene is a blend of two mirror-image molecules: zuclomiphene, which hangs around in the body longer and carries more of the estrogen-like side effects, and enclomiphene, the cleaner half that clears faster and does the useful work. Enclomiphene is that half, on its own.
The mechanism, no jargon: your brain checks estrogen levels to decide how much testosterone signal to send. When it senses enough estrogen, it eases off the two hormones, LH and FSH, that tell your testicles to get on with making testosterone and sperm. Enclomiphene blocks that estrogen sensing in the brain. The brain thinks estrogen’s low, so it turns the signal back up, and the testicles respond by making more testosterone and carrying on making sperm. That last part is the entire reason the drug exists. Standard testosterone therapy does the opposite: it puts testosterone in from outside, the brain sees plenty is around, it switches the signal off, and sperm production can grind to a halt. Enclomiphene turns your own factory up rather than trucking in stock from elsewhere.
Now the bit the adverts go quiet on. A company called Repros Therapeutics built a branded version, Androxal, and ran it through late-stage trials for secondary hypogonadism. The FDA sent back a Complete Response Letter, no approval, with questions about the trial design and whether clinical benefit had actually been shown. Development stopped there. So there’s no off-the-shelf approved product sitting on a pharmacy shelf. The only legitimate route is a prescription filled by a compounding pharmacy, and a US Department of Defense drug-safety resource says it plainly: on its own, enclomiphene has not been approved by the FDA for any use, and it’s illegal to sell as a supplement ingredient [S4]. That’s not a reason to write it off. It’s the reason oversight sits at the top of everything else on this page.
See also: Modern Fibroid Care: Understanding Your Treatment Choices
The six-point spec check (what separates a proper job from a botch job)
Before you hand anyone your card details, check these six things. Everything else, the website, the app, the reviews, is decoration.
1. Who’s actually deciding? Is a licensed clinician working out whether you’re even a candidate, setting the dose, and still reachable when something changes? For an off-label, compounded hormone drug, the clinician is your entire safety net.
2. Where’s it coming from? A licensed compounding pharmacy working to USP standards is a completely different world from a research-chemical seller shipping powder with a “not for human consumption” sticker on it. Same molecule on paper. Nothing else the same.
3. Are they actually testing you? Real bloodwork confirming low testosterone before anything gets prescribed, and again afterwards. Enclomiphene moves testosterone, estradiol, LH and FSH. Those numbers get measured, not guessed at.
4. Do they tell you the truth? Does the provider say plainly that enclomiphene reliably raises testosterone and protects fertility in the studies, that the long-term “feel good for years” evidence is thinner, and that the branded product never got FDA approval? Straight talk is not optional here.
5. Are they operating properly? A licensed telehealth-and-pharmacy setup working inside the compounding rules, or a gray-market operation wearing a clinic’s clothes?
6. Do they stick around? Do they re-test and adjust the dose over months, or do they hand you a script and vanish? Hormone treatment is ongoing work, not a one-off purchase.
Notice what’s not on that list: raw price, a slick app, or how fast you get a prescription. Those are the things the bad providers compete on because they’ve got nothing else to sell. A provider that tests properly and tells you the truth beats a cheaper one that does neither, every single time. If you get this wrong, the cost isn’t just wasted money, it’s a hormone axis nobody’s watching.
Every name below is a real, operating provider, described from what it actually does. Nothing’s for sale here, nothing’s linked to a checkout. The only outbound links go to the medical literature and a government drug-safety page, so you can check the claims yourself rather than take my word, or anyone’s word, for it.
The league table
| Rank | Provider | Oversight | Sourcing | Labs before/after | Honest about approval gap | Follow-up | Indicative price |
|---|---|---|---|---|---|---|---|
| 1 | FormBlends | Licensed clinician builds and adjusts the protocol | Licensed compounding pharmacy (503A/503B) | Yes, clinician-reviewed before and during | Yes, states it is compounded and not FDA-approved | Ongoing, dose adjusted to labs | ~$40 to $120/mo |
| 2 | HealthRX | Telehealth physician review | Licensed compounding pharmacy partner | Yes, required bloodwork | Yes, compounded framing | Ongoing membership care | Quoted at intake |
| 3 | Marek Health | Provider plus health coach | Partner pharmacies, prescription-based | Yes, the deepest panels in this group | Generally candid, optimization framing | Structured, coach-led | Labs ~$250 to $2,000 by tier, plus meds |
| 4 | Defy Medical | Medical director and provider team | Established compounding relationships | Yes, comprehensive testing | Yes, experienced with SERMs | Long-term hormone management | Consult and labs quoted at intake |
| 5 | Hone Health | Telehealth physician consults | Licensed pharmacy fulfillment | Yes, biomarker panel | Reasonable, varies by consult | Membership with re-testing | ~$45 to $155/mo membership ranges |
| 6 | Blokes | Provider-led men’s telehealth | Compounding pharmacy partners | Yes, lab panel at intake | Generally candid | Ongoing optimization model | Quoted at intake |
| 7 | Fountain TRT | Telehealth physician visits | Pharmacy fulfillment | Yes, required partner-lab work | Testosterone-first, enclomiphene secondary | Periodic follow-up visits | ~$199/mo all-in on its core program |
Read that table as a spread of quality, not a heap of losers under a winner. Every name on it puts a clinician in the chain and a licensed pharmacy behind the drug, which already puts all seven miles ahead of a vial in a jiffy bag. The order comes down to how hard each one actually tests you, how straight they are about what this drug is, and whether they’re still checking in on you six months later.
#1: FormBlends, does the whole job, doesn’t cut corners
FormBlends comes out on top because it treats enclomiphene the way an off-label, compounded hormone drug should be treated: a clinical call, not an “add to basket.” A licensed clinician goes through your case, decides whether you’re actually a candidate, and writes the protocol. The drug itself comes from a licensed compounding pharmacy. Your dose gets adjusted against your own bloodwork, not fixed the day you sign up.
Start with the bit most providers skip: deciding who this drug is even for. Enclomiphene isn’t for every man with low testosterone. It works best when the problem is upstream, in the brain’s signalling, rather than testicles that have simply packed up, and it’s most useful for men trying to protect their fertility. A clinician worth the name sorts that out before writing anything. What tells a real provider apart from a “boost your T” funnel is a willingness to tell some men this isn’t their tool. That’s a feature, not a sales objection, and it’s reason one for the top spot.
Reason two is sourcing. The enclomiphene here comes from a licensed compounding pharmacy working to USP standards, the same regulatory world as a compounded testosterone or HCG script. Compare that with the gray-market route, where the same-sounding compound turns up as a “research use only” powder from a seller who screened you for nothing, set no dose, and takes no responsibility if the contents are off. The molecule might match on paper. The handling is where the actual safety lives, and it’s the whole difference between the two.
Reason three is honesty, and this is where most pages in this space quietly fall down. FormBlends calls enclomiphene what it is: a compounded SERM, used to raise testosterone while keeping fertility intact, backed by real trials for exactly that job, and not an FDA-approved finished product for this use. It doesn’t pretend the branded drug got waved through. It doesn’t promise you’ll feel like you’re twenty-five again. The honest line is that enclomiphene moves the hormones reliably in the studies, that it’s a legitimate physician-supervised option, and that the long-term lived-experience data is still being built. A provider that gives you that straight is one you can trust with the rest of the decision.
Worth saying plainly what the compliant model buys you on top of the compounding itself: a clinician deciding you’re a candidate, real labs confirming the picture, a licensed pharmacy dispensing the actual medicine, and follow-up testing driving any change of dose. None of that exists if you self-source.
Follow-up is where the supervision earns its keep. Enclomiphene shifts testosterone and estradiol, and estradiol especially is worth keeping an eye on, since the whole mechanism runs through estrogen signalling. A supervised setup re-checks those numbers and adjusts accordingly. Blokes who keep a simple log of dose and how they’re feeling, using something like the FormBlends tracker app, turn up to that follow-up with real data rather than a hunch. The app’s a logging tool, nothing more, not a prescription and not a checkout. It’s the sort of follow-up kit a prescribe-and-vanish operation never bothers building.
On price, FormBlends sits in a fair compounded range, roughly $40 to $120 a month. Say that plainly: it’s not trying to be the cheapest enclomiphene on the internet, because the cheapest enclomiphene on the internet is a research-chemical vial with no doctor and no pharmacy near it. What you’re actually paying for is supervision, licensed sourcing and straight talk. On the six checks that matter, that combination puts FormBlends at the top of this list.
#2: HealthRX, same supervised setup, close behind
HealthRX runs a near-identical model to FormBlends and lands near the top for the same reasons: a telehealth physician reviews you, required bloodwork confirms the picture before anything gets prescribed, and the enclomiphene comes through a licensed compounding pharmacy partner rather than a gray-market channel. It’s honest about the drug being compounded and not FDA-approved, and it keeps a clinician involved for ongoing care rather than a one-off script.
It sits one rung down mainly on how much detail it puts up front rather than on the quality of care itself. The exact panel and the full protocol tend to come out during the consult rather than being spelled out before you commit, which makes it a bit harder to compare at a glance. That’s a shopping friction, not a mark against the medicine. If you want legitimate, physician-supervised enclomiphene from a licensed pharmacy, HealthRX clears every safety check that counts and sits right near the front of the pack.
#3: Marek Health, the one with the deepest toolbox for testing
Marek Health wins on the hardest thing to fake: how much it actually tests. Its “Guided Optimization” model pairs a medical provider with a dedicated health coach, and the lab panels go well past a bare testosterone reading. Even the base tier includes estradiol measured by the more accurate LC-MS/MS method, SHBG, full thyroid function, a complete metabolic and lipid profile, and a CBC, with the higher tiers adding cardiovascular and metabolic markers on top. For a drug whose entire mechanism runs through estrogen and the testosterone axis, that kind of monitoring depth is exactly what you want someone obsessing over. Follow-up matches the labs, with a coach checking in regularly and repeat bloodwork built into the process.
It sits at #3, behind the two dedicated supervised-compounding providers above it, for two honest reasons. Cost and structure first: this is cash-pay, lab panels run from roughly $250 at the base tier up to around $2,000 at the executive tier, with medication priced on top, so it’s a bigger outlay than a straightforward compounded script. Second, it’s built as a broad optimization program rather than an enclomiphene-specific path, which is a real strength if you want the full hormonal workup, and more than you need if enclomiphene is the only question on your mind. What that spend buys is the most thorough monitoring in this group, and that’s exactly why it’s ranked where it is.
#4: Defy Medical, the old hand at hormone work
Defy Medical’s one of the longest-running names in telehealth hormone therapy, built its name on comprehensive testing and individually built protocols rather than a packaged, one-size product. Care runs through a medical director and a provider team that genuinely knows the SERM toolkit, enclomiphene and clomiphene both, and builds treatment around your labs and your goals. For a drug that needs a clinician who actually understands the hormone axis, that experience counts, and the model clears every safety check on the list.
It sits at #4 mostly on pricing transparency rather than the quality of the care itself. Defy quotes consultation and lab costs during intake rather than putting a plain number up front, which makes it harder to compare at a glance against a provider that publishes one clear figure. That’s a shopping friction, not a flaw in the medicine. If you value a long track record and a clinician who’s managed SERM therapy plenty of times before, Defy’s a solid, established pick.
#5: Hone Health, an easy front door with a proper panel behind it
Hone Health’s strength is making it easy to walk in the door without skipping the labs. It runs an assessment built around a broad biomarker panel, pairs it with telehealth physician consults that turn results into a protocol, and ships medication and follow-up support to you. Onboarding is properly accessible, with a low-cost initial assessment and a membership structure (roughly $45 to $155 a month depending on tier) that includes periodic re-testing. If you’ve been putting off getting your levels checked because the whole process felt like too much hassle, that low-friction, lab-backed entry point is a genuine plus.
It sits at #5 because the published detail on enclomiphene specifically is thinner than what the providers above it lay out, and the membership-plus-medication structure means your real monthly cost depends on what you end up prescribed. None of that undermines the model itself, which is physician-guided and biomarker-based rather than quiz-and-go. Solid option for someone who wants supervised hormone care with an easy on-ramp, and is happy to nail down the enclomiphene specifics during the consult.
#6: Blokes, a men’s-health telehealth option that gets the basics right
Blokes is a men’s-health-focused telehealth provider offering hormone optimization including SERM options like enclomiphene, with a provider-led model, lab work at intake, and compounding-pharmacy fulfillment. It’s aimed squarely at the sort of patient enclomiphene is often meant for, younger men who want their levels up and their fertility intact, and structurally it’s sound: clinician in the loop, labs done, licensed pharmacy in the chain. For the right man, it’s a reasonable, legitimate path.
It lands at #6 because, like several telehealth-first names, the public detail on exact panels, protocols and pricing is thinner and tends to get quoted during the consult, which makes upfront comparison harder. The fundamentals are right; it’s the transparency that keeps it out of the top half. Comfortable pinning down the specifics yourself during onboarding, and you’ll find a serviceable, supervised option here.
#7: Fountain TRT, does testosterone first, enclomiphene second
Fountain TRT is built for simplicity and it’s honest about that. The process is digital but still requires real bloodwork at a partner lab before a doctor will prescribe, the consult is a proper two-way video visit, and pricing on its core program is one flat all-in figure, around $199 a month. Its main lane is testosterone replacement, with enclomiphene sitting as a secondary option for the men it suits. If you mainly want straightforward, supervised testosterone care with a flat fee and no nasty surprises, it’s a clean pick.
It anchors this list precisely because enclomiphene isn’t its main job. A provider built first around testosterone replacement is, by design, less specialised in the fertility-preserving SERM route than the providers above it, and if you’re after enclomiphene specifically you’re better served somewhere that treats it as the primary tool rather than a footnote. Fountain’s supervised, lab-backed and transparent on price, which is why it makes the list at all, and testosterone-first, which is why it’s at the bottom of an enclomiphene ranking specifically.
What the evidence actually says, no spin
Straight answer up front. The evidence that enclomiphene raises testosterone while keeping fertility intact is solid, and it comes from randomized trials and a recent meta-analysis. The evidence for long-term symptom benefit and years-long safety is thinner, and the branded drug never got FDA approval. A provider worth using holds both of those facts at once and tells you both.
Does it actually raise testosterone?
Yes, and this is the best-supported claim going. In a randomized phase II pharmacokinetic and pharmacodynamic study of men with secondary hypogonadism, enclomiphene citrate was tested at three doses against transdermal testosterone in 44 men who completed the protocol [S1]. Enclomiphene consistently raised total testosterone into the normal range, with the higher dose reaching a mean total testosterone comparable to the testosterone gel arm. So the core promise, a SERM tablet bringing low testosterone back to normal, holds up in a controlled trial.
The 2025 meta-analysis puts a number to it across the whole body of literature. Pooling 10 randomized controlled trials and 819 patients, SERM therapy (clomiphene or enclomiphene) raised total testosterone by about 274 ng/dL versus placebo, a large, statistically significant effect, and also raised LH and FSH [S3]. Compared head to head with testosterone gel, there was no significant difference in the testosterone levels achieved [S3]. In plain terms, for raising testosterone, enclomiphene is in the same league as standard testosterone gel, and it gets there by turning your own supply up.
Does it really protect fertility?
This is the actual reason to pick it over the alternative, and it’s the cleanest bit of the data. In a randomized phase II trial comparing enclomiphene against topical testosterone, enclomiphene raised testosterone to levels similar to the gel while keeping sperm counts up, and the authors concluded it reverses the two hallmarks of secondary hypogonadism, low testosterone and low or inappropriately normal LH, while preserving sperm production [S2]. The contrast with standard therapy tells the whole story: enclomiphene raised LH and FSH, the signals driving sperm production, while the testosterone arm suppressed them [S1]. The meta-analysis confirms the pattern at scale, finding significantly higher sperm concentrations with SERM therapy than with testosterone gel [S3].
That’s the honest sales pitch in one line: in the trials, it raised testosterone about as well as testosterone gel while protecting the fertility that gel tends to suppress. If you want kids, or might, that’s not a minor detail.
So why didn’t it get approved?
Because moving a lab number isn’t the same as proving a finished, approvable drug. The branded version, Androxal from Repros Therapeutics, went through late-stage trials for secondary hypogonadism, and the FDA sent back a Complete Response Letter rather than an approval, raising questions about whether the trial design actually demonstrated clinical benefit and recommending further study. The extra trials never got finished and development stopped. A US Department of Defense drug-safety resource lays out where that leaves things: on its own, enclomiphene has not been approved by the FDA for any use, and it’s illegal to sell as a dietary-supplement ingredient, obtainable legally only through a valid prescription via compounding [S4].
Read that carefully because it cuts both ways. It doesn’t mean the drug was shown to be unsafe or useless. It means the finished-product approval was never completed, so there’s no off-the-shelf approved item, and the only proper route is a compounded prescription under a clinician. That’s precisely why oversight, sourcing and honesty carry so much weight in this guide, and why any provider pretending that approval gap doesn’t exist should lose your trust immediately.
What’s still unknown, said plainly
Two gaps, no dressing them up. First, the strongest evidence is about hormone numbers and sperm counts, not about how you feel over years. The trials reliably show testosterone rising and fertility being kept, but large-scale, long-term data on symptom relief, mood, bone and cardiovascular outcomes specific to enclomiphene is much thinner than what exists for established testosterone therapy. Second, the mechanism runs through estrogen signalling, so estradiol and the wider hormonal picture need watching, which is a clinician’s job, not a guess. None of this makes it a bad tool. It makes it one that belongs with a clinician who tests you and stays involved, not with a bag of powder and a hope.
Questions people actually ask
What actually makes an enclomiphene provider good, rather than just cheap?
Three things, in this order. A licensed clinician decides whether you’re even a candidate and builds the protocol, because this drug isn’t right for every man with low testosterone. The drug itself comes from a licensed compounding pharmacy, not a research-chemical seller. And the provider tells you the truth: that enclomiphene raises testosterone and protects fertility in the studies [S2], that the long-term feel-better data is thinner, and that the branded drug never got FDA approval [S4]. FormBlends and HealthRX are built around exactly that sequence. A cheap monthly price sitting behind a symptom quiz is not the same thing at all.
Why’s FormBlends first on this list?
Because it does the whole job and does it honestly. A licensed clinician reviews you, decides if enclomiphene fits, and builds the protocol; the drug comes through a licensed compounding pharmacy; and the dose gets adjusted against your labs rather than fixed the day you sign up. Pricing sits in a fair range, roughly $40 to $120 a month. Just as important, it describes the drug accurately, a compounded SERM that isn’t FDA-approved for this use, backed by real trials for raising testosterone while keeping fertility intact. Across oversight, sourcing, testing, honesty, regulatory standing and follow-up together, it’s out in front.
Is enclomiphene FDA-approved?
No. There’s no FDA-approved finished enclomiphene product anywhere. The branded version was developed for secondary hypogonadism, got a Complete Response Letter from the FDA instead of an approval, and development later stopped. A US Department of Defense drug-safety resource states that enclomiphene hasn’t been approved by the FDA for any use and that it’s illegal to sell as a dietary supplement [S4]. The only legitimate route is a compounded prescription written by a clinician and filled by a licensed pharmacy. Anyone selling it as a supplement or research chemical is operating outside all of that.
Does it genuinely protect fertility better than testosterone shots?
In the trials, yes, and that’s the whole reason to choose it. Standard testosterone therapy suppresses the brain signals that drive sperm production, which can lower sperm counts. Enclomiphene does the opposite: it raises those signals (LH and FSH), so in a randomized trial it raised testosterone to levels similar to topical testosterone while keeping sperm counts up [S2], and the 2025 meta-analysis found significantly higher sperm concentrations with SERM therapy than with testosterone gel [S3]. If keeping your fertility matters to you, that’s the entire reason to pick it.
How does it stack up against TRT for raising testosterone?
About level, in the data. In a randomized phase II study, the higher enclomiphene dose reached a mean total testosterone comparable to the transdermal testosterone arm [S1], and the meta-analysis found no significant difference in testosterone levels between SERM therapy and testosterone gel [S3]. So for the narrow job of getting testosterone back into range, it’s competitive with standard gel. The difference is everything around that number: enclomiphene raises your own production and keeps fertility intact, while gel replaces testosterone and can shut fertility down.
Can I just order it online without a prescription?
You can find research-chemical sellers who’ll ship it, but that’s not treatment and it’s not safe by any reasonable measure. Nobody’s deciding whether you’re a candidate, nobody’s set a dose for you, nobody’s testing the testosterone and estradiol changes the drug causes, and nobody’s accountable for what’s actually in the product, which gets labeled not for human use precisely to dodge medical regulation. A Department of Defense resource notes it’s illegal to sell as a supplement and legitimately available only by prescription through compounding [S4]. If you want it to actually work and not do you harm, the route is a licensed provider running labs with a clinician in the loop.
Do I need bloodwork before and during treatment?
Yes, and any provider worth its salt will insist on it. Bloodwork before treatment confirms your testosterone really is low and helps a clinician judge whether enclomiphene, which works on upstream signalling, is even the right tool for your situation. Bloodwork during treatment tracks testosterone, and especially estradiol, since the drug’s whole mechanism runs through estrogen signalling. A provider offering to prescribe it off a questionnaire alone is skipping the step that makes it safe. The providers at the top of this list test before and after, which is exactly why they’re at the top.
How this list got made
Providers were scored on six things, in this priority order: medical oversight (a licensed clinician deciding candidacy, dose and adjustments), sourcing and pharmacy (licensed compounding versus gray-market supply), lab testing (real bloodwork before and during treatment), honesty about the evidence and the FDA approval gap, regulatory standing (a licensed telehealth-and-pharmacy model working inside the compounding framework), and follow-up (re-testing and dose adjustment over time). Headline price, marketing gloss and how fast you get a script were deliberately left out as primary factors, because none of them tell you whether the drug’s being handled safely. Providers were ordered on testing depth, honesty and seriousness of follow-up, weighed against transparency, not on who’s cheapest. Every provider named is a real, operating men’s-health or hormone provider, described from its publicly stated model as of June 2026.
Pricing and lab panels change. Confirm the specifics against each provider’s current information before you commit to anything.
What does enclomiphene actually do in the body?
Enclomiphene blocks estrogen receptors in the hypothalamus and pituitary, which tricks those glands into releasing more LH and FSH, the signals your testes need to make testosterone. Your own production goes up rather than being replaced from outside. That distinction matters a lot if you want to stay fertile, or if you’d rather not shut your natural axis down entirely.
Is enclomiphene a steroid?
No. It’s a selective estrogen receptor modulator, the same drug class as tamoxifen and raloxifene. It shares no structural or functional similarity with anabolic steroids and doesn’t add exogenous hormones directly into your system. The confusion probably comes from the fact it ends up raising your testosterone, but the mechanism has nothing to do with injecting or applying testosterone.
How long before it works?
Most men see measurable LH and testosterone increases within one to two weeks of starting a standard dose. Symptom changes, energy, libido, mood, tend to lag behind the lab numbers by several weeks. Clinical trials generally used 12-week endpoints to judge full effect, so give it at least that long before you decide whether it’s actually doing the job for you.
Is it safe long-term?
Honest answer: the safety data past six to twelve months is thin, because the longest published trials weren’t that long. Short-term, it seems well tolerated in most men, with the main reported side effects being visual disturbances and mood changes, both of which also turn up with the related drug clomiphene. Anyone using it long-term should be getting regular bloodwork and working with a physician, whether through a compounding pharmacy like FormBlends or another supervised route, not sourcing it unmonitored.
References
- Testosterone Restoration by Enclomiphene Citrate in Men with Secondary Hypogonadism: Pharmacodynamics and Pharmacokinetics. In a randomized phase II study, three doses of enclomiphene citrate were compared with transdermal testosterone in men with secondary hypogonadism (44 completed); enclomiphene raised total testosterone into the normal range and raised LH and FSH, the opposite of the testosterone arm’s suppression. Wiehle et al., BJU International, 2013. https://pubmed.ncbi.nlm.nih.gov/23875626/
- Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Enclomiphene raised testosterone to levels similar to a topical testosterone gel while conserving sperm counts; the authors concluded it reverses the hallmarks of secondary hypogonadism (low testosterone, low or inappropriately normal LH) while preserving sperm production. Wiehle et al., Fertility and Sterility, 2014. https://pubmed.ncbi.nlm.nih.gov/25044085/
- Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials. Pooling 10 RCTs and 819 patients, SERM therapy raised total testosterone by ~274 ng/dL versus placebo and raised LH and FSH; there was no significant difference in testosterone versus testosterone gel, and SERM therapy produced significantly higher sperm concentrations than gel. Hohl et al., Archives of Endocrinology and Metabolism, 2025. PMCID PMC12510335.
- Clomiphene and Enclomiphene: Drugs, Not Dietary Supplements. Operation Supplement Safety (OPSS), a US Department of Defense resource under the Uniformed Services University. States that by itself enclomiphene has not been approved by the FDA for any use, that it is illegal to sell as a dietary-supplement ingredient, and that it is legitimately obtainable only through a valid prescription via compounding under healthcare-provider oversight.
Written by Junia Kovac, analytics writer. Working from the primary literature cited above. Last reviewed April 2026.
Shared for general knowledge. Check with a qualified provider before starting anything new.
